Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease

ClinicalTrials.gov ID: NCT04616924

Public ClinicalTrials.gov record NCT04616924. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 8:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Study of RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease in Adults With Nodular Bronchiectasis (CleaR-MAC Trial)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A 2-part multi-center, Phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of RHB-204 in adult subjects with underlying nodular bronchiectasis and documented MAC lung infection.

Study identification

NCT ID
NCT04616924
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
RedHill Biopharma Limited
Industry
Enrollment
12 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 1, 2020 (Actual)
Primary completion
Aug 28, 2023 (Actual)
Completion
Aug 28, 2023 (Actual)
Last update posted
Mar 18, 2025

2020 – 2023

United States locations

U.S. sites
25
U.S. states
17
U.S. cities
24
Facility City State ZIP Site status
Medical Facility Glendale California 91205 —
Medical Facility Palm Springs California 92262 —
Medical Facility Farmington Connecticut 06030-1225 —
Medical Facility Washington D.C. District of Columbia 20007 —
Medical Facility Clearwater Florida 33765 —
Medical Facility Gainesville Florida 32610 —
Medical Facility Margate Florida 33063 —
Medical Facility 1 Orlando Florida 32803 —
Medical Facility 2 Orlando Florida 32803 —
Medical Facility Sebring Florida 33870 —
Medical Facility Vero Beach Florida 32960 —
Medical Facility Atlanta Georgia 30342 —
Medical Facility Valdosta Georgia 31605 —
Medical Facility Kansas City Kansas 66160 —
Medical Facility New Orleans Louisiana 70112 —
Medical Facility Boston Massachusetts 02215 —
Medical Facility Rochester Minnesota 55902 —
Medical Facility St Louis Missouri 63110 —
Medical Facility Newark New Jersey 07103 —
Medical Facility New York New York 10029 —
Medical Facility Winston-Salem North Carolina 27103 —
Medical Facility Portland Oregon 97239 —
Medical Facility Charleston South Carolina 29425 —
Medical Facility Tyler Texas 75708 —
Medical Facility Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04616924, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 18, 2025 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04616924 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →